Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China

Junnan Shi, Hao Hu, Carolina Oi Lam Ung

Open source

DOI
10.1016/j.reth.2026.101102
Published
2026-06
Container
Regenerative Therapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.reth.2026.101102,
  title = {Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China},
  author = {Junnan Shi and Hao Hu and Carolina Oi Lam Ung},
  year = {2026},
  journal = {Regenerative Therapy},
  doi = {10.1016/j.reth.2026.101102},
  url = {https://doi.org/10.1016/j.reth.2026.101102}
}

RIS

TY  - JOUR
TI  - Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China
AU  - Junnan Shi
AU  - Hao Hu
AU  - Carolina Oi Lam Ung
PY  - 2026
JO  - Regenerative Therapy
DO  - 10.1016/j.reth.2026.101102
UR  - https://doi.org/10.1016/j.reth.2026.101102
ER  - 

APA

Shi, J., Hu, H., & Ung, C. O. L. (2026). Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China. Regenerative Therapy. https://doi.org/10.1016/j.reth.2026.101102

Source records